Blanket Purchase Agreement 36F79719D0169-36C25524A0025
Award Date
3/28/24
Last Date to Order
7/31/25
Federal Agency
Veterans Integrated Service Network 15
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 9, has awarded a single-award Blanket Purchase Agreement (BPA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The BPA has a ceiling value of $49,212,356.34 and a period of performance from December 2024 to November 2029, with five ordering periods. The BPA is for the manufacture and delivery of Pluvicto (lutetium Lu 177...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The $7.5 million single-award BPA, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), covers the delivery of PLUVICTO and LUTATHERA, which are radiopharmaceutical products used for cancer treatment and diagnostic imaging. The VA has awarded Advanced Accelerator...
This Blanket Purchase Agreement (BPA) contract was awarded by the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract has a total ceiling value of $6,900,000 and a period of performance through September 30, 2025. The primary purpose of this contract is to procure the radiopharmaceutical product PLUVICTO, which is used in cancer treatment and diagnostic...
This federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract has a ceiling value of $6,000,000 and a period of performance from January 1, 2025 through December 31, 2025. The primary product being procured under this BPA is the radiopharmaceutical...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $1.9 million firm fixed price blanket purchase agreement call contract to Advanced Accelerator Applications USA Inc. to provide PLUVICTO. The contract was awarded under the Pharmaceuticals and Drugs master GSA schedule and has a period of performance from August 2, 2023 through January 31, 2024 in Millburn, New Jersey. The originating special notice federal contract opportunity...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 awarded a single award blanket purchase agreement to Advanced Accelerator Applications USA Inc. to provide PLUVICTO and LUTATHERA radiopharmaceuticals. With a period of performance from December 1, 2022 through November 30, 2023 and a value of approximately $4.37 million, this firm fixed price contract utilizes Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. Performance will take...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a blanket purchase agreement to Advanced Accelerator Applications USA Inc. to deliver doses of the pharmaceutical PLUVICTO. The BPA has a potential value of $7,790,954.40 and a period of performance through December 2024. Two task orders have been issued against this BPA. The first task order, awarded in January 2024, is valued at $1,688,040.12 to provide PLUVICTO doses through...
The Defense Health Agency (DHA) awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $26,050,385.01 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract is for the procurement of the cancer therapy drugs LUTATHERA (lutetium Lu 177 dotatate) and PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) over a period of 5 years from October 1, 2024 to September 30, 2029. The original solicitation was a Sources...
The federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The single-award BPA has a ceiling value of $1,900,000.00 and a period of performance ending on September 30, 2029. The primary purpose of this contract is to procure PLUVICTO and LUTATHERA injection, which are specialized radiopharmaceutical products...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Advanced Accelerator Applications USA Inc., a large, foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $23.4 million single-award BPA is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of February 3, 2025. The BPA is for the procurement of LOCAMETZ and NETSPOT, two...